Search research articles
Contact Us
Filters
Showing results (581-590 of 612) with videos related to
Page
of 62
Sort By:
The Canadian Journal of Cardiology
|
March 5, 2014
Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel
Todd J Anderson, Jean Grégoire, Robert A Hegele, et al.
JACC. Cardiovascular Imaging
|
January 17, 2021
CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial
G B John Mancini, Jonathan Leipsic, Matthew J Budoff, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
The Canadian Journal of Cardiology
|
August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
G B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
The Canadian Journal of Cardiology
|
August 11, 2018
Simplified Canadian Definition for Familial Hypercholesterolemia
Isabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
The Canadian Journal of Cardiology
|
March 30, 2021
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J Pearson, George Thanassoulis, Todd J Anderson, et al.
The New England Journal of Medicine
|
March 28, 2007
Optimal medical therapy with or without PCI for stable coronary disease
William E Boden, Robert A O'Rourke, Koon K Teo, et al.
Circulation
|
February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
Leslee J Shaw, Daniel S Berman, David J Maron, et al.
Atherosclerosis
|
June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in Canada
Zobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
Circulation. Cardiovascular Interventions
|
April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial
Sripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 612) with videos related to
Sort By:
Page
of 62
The Canadian Journal of Cardiology
|
March 5, 2014
Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel
Todd J Anderson, Jean Grégoire, Robert A Hegele, et al.
JACC. Cardiovascular Imaging
|
January 17, 2021
CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial
G B John Mancini, Jonathan Leipsic, Matthew J Budoff, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
The Canadian Journal of Cardiology
|
August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
G B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
The Canadian Journal of Cardiology
|
August 11, 2018
Simplified Canadian Definition for Familial Hypercholesterolemia
Isabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
The Canadian Journal of Cardiology
|
March 30, 2021
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J Pearson, George Thanassoulis, Todd J Anderson, et al.
The New England Journal of Medicine
|
March 28, 2007
Optimal medical therapy with or without PCI for stable coronary disease
William E Boden, Robert A O'Rourke, Koon K Teo, et al.
Circulation
|
February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
Leslee J Shaw, Daniel S Berman, David J Maron, et al.
Atherosclerosis
|
June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in Canada
Zobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
Circulation. Cardiovascular Interventions
|
April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial
Sripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Page
of 62